Dr. Niven R. Narain is the Co-Founder, President & CEO of Berg, a Boston-based biopharma that combines patient-driven biology and Bayesian AI for next-generation drug and diagnostic development. He is a pioneer in technology development at the intersection of Biology and AI and is known for his work on the Interrogative Biology® platform, which has led to the development of a deep pipeline of products in oncology, metabolic, rare, and CNS diseases. Dr. Narain is a thought leader in precision medicine, drug development, and AI/ML and has been recognized for his contributions to the field with several prestigious awards and honors.